Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-018-1667-y
Abstract: BackgroundRenal resistive index (RI) calculated using renal Doppler ultrasonography (RDU) has recently been considered a clinically important indicator of renal outcome, survival, and systemic arteriosclerotic disorders. However, the cause of RI elevation remains unclear. The… read more here.
Keywords: resistive index; renin angiotensin; effect renin; elevation ... See more keywords
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Sign Up to like & getrecommendations! Published in 2021 at "American Heart Journal"
DOI: 10.1016/j.ahj.2021.04.001
Abstract: BACKGROUND The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. METHODS HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are… read more here.
Keywords: hope covid; covid; renin angiotensin; angiotensin system ... See more keywords
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.
Sign Up to like & getrecommendations! Published in 2021 at "American heart journal"
DOI: 10.1016/j.ahj.2021.09.014
Abstract: BACKGROUND Stopping renin-angiotensin system inhibitors (RASi) after an episode of hyperkalemia is common but may involve therapeutic compromises, in that the cessation of RASi deprives patients of their beneficial cardiovascular effects. METHODS AND RESULTS Observational… read more here.
Keywords: risk; renin angiotensin; hyperkalemia; stopping renin ... See more keywords
RENIN ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CORONARY ARTERY DISEASE AND PRESERVED LEFT VENTRICULAR FUNCTION
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)33475-7
Abstract: Background: Renin angiotensin system inhibitors (RASi) are recommended (Class I LoE A ) for patients with coronary artery disease (CAD) without heart failure. However, more recent trials with improved background therapy (and lower event rates)… read more here.
Keywords: patients coronary; artery disease; coronary artery; renin angiotensin ... See more keywords
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Critical Care Medicine"
DOI: 10.1097/ccm.0000000000005627
Abstract: OBJECTIVES: To determine the association of prior use of renin-angiotensin-aldosterone system inhibitors (RAASIs) with mortality and outcomes in hospitalized patients with COVID-19. DESIGN: Retrospective observational study. SETTING: Multicenter, international COVID-19 registry. Subjects: Adult hospitalized COVID-19… read more here.
Keywords: angiotensin aldosterone; aldosterone system; system inhibitors; mortality ... See more keywords
Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?
Sign Up to like & getrecommendations! Published in 2023 at "Current opinion in nephrology and hypertension"
DOI: 10.1097/mnh.0000000000000878
Abstract: PURPOSE OF REVIEW To discuss recent evidence on the benefits and harms of stopping therapy with renin-angiotensin-aldosterone system inhibitors (RAASi) after the occurrence of adverse events or in patients with advanced chronic kidney disease (CKD).… read more here.
Keywords: system inhibitors; aldosterone system; angiotensin aldosterone; renin angiotensin ... See more keywords
Renin-angiotensin system inhibitors in patients with or without ischaemic mitral regurgitation after acute myocardial infarction
Sign Up to like & getrecommendations! Published in 2017 at "Open Heart"
DOI: 10.1136/openhrt-2017-000637
Abstract: Objective Little is known about the long-term effects of renin–angiotensin system inhibitors (RASI) on cardiovascular events in patients after acute myocardial infarction (AMI) with ischaemic mitral regurgitation (IMR). The purpose of this study was to… read more here.
Keywords: patients imr; renin angiotensin; acute myocardial; angiotensin system ... See more keywords
Abstract 957: Use of angiotensin system inhibitors is associated with longer overall survival in pancreatic ductal adenocarcinoma patients who underwent pancreatectomy
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-957
Abstract: Introduction: Angiotensin system inhibitors (ASI) are widely used to manage hypertension. Laboratory and retrospective clinical data suggests that ASIs can improve cancer prognosis. The aim of this study is to investigate the effect of ASIs… read more here.
Keywords: use; overall survival; angiotensin system; longer overall ... See more keywords
Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the American Thoracic Society"
DOI: 10.1513/annalsats.202207-615oc
Abstract: RATIONALE Adult sepsis survivors have an increased risk of experiencing long-term cardiovascular events. OBJECTIVE To determine whether the cardiovascular risk following sepsis is mitigated by renin-angiotensin system inhibitors (RASi). METHODS Population-based cohort study of adult… read more here.
Keywords: sepsis; angiotensin system; system inhibitors; renin angiotensin ... See more keywords
Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.829059
Abstract: Bevacizumab (Bev) is a humanized vascular endothelial growth factor monoclonal antibody that is used with chemotherapeutic drugs for the treatment of metastatic colorectal cancer (mCRC). Bev-induced hypertension (HT) is the most common adverse reaction during… read more here.
Keywords: extracellular matrix; effect; angiotensin system; system inhibitors ... See more keywords
A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23073915
Abstract: A major paradigm in nephrology states that the loss of filtration function over a long time is driven by a persistent hyperfiltration state of surviving nephrons. This hyperfiltration may derive from circulating immunological factors. However,… read more here.
Keywords: hemodynamics; immunology; renin angiotensin; system inhibitors ... See more keywords